Diarrhea (peds): Difference between revisions
ClaireLewis (talk | contribs) |
ClaireLewis (talk | contribs) |
||
| Line 91: | Line 91: | ||
|- | |- | ||
| align="left" | ''[[Salmonella]]'' species | | align="left" | ''[[Salmonella]]'' species | ||
| align="left" | ''In toxic infants <3'' ''mo''<nowiki>:</nowiki><br>Ampicillin 200mg/kg/24 hours q6h for 7–10 days ''and''<br>Gentamicin 5–7.5mg/kg/24 hours q8h IV | | align="left" | ''In toxic infants <3'' ''mo''<nowiki>:</nowiki><br>[[Ampicillin]] 200mg/kg/24 hours q6h for 7–10 days ''and''<br>[[Gentamicin]] 5–7.5mg/kg/24 hours q8h IV | ||
|- | |- | ||
| align="left" rowspan="2" | ''Shigella'' species | | align="left" rowspan="2" | ''Shigella'' species | ||
| align="left" | Azithromycin 12mg/kg/day PO for 5 days ''or'' | | align="left" | [[Azithromycin]] 12mg/kg/day PO for 5 days ''or'' | ||
|- | |- | ||
| align="left" | [[Trimethoprim-sulfamethoxazole]] 10mg (TMP)/kg/day, divided, BID for 5–7 days if susceptible | | align="left" | [[Trimethoprim-sulfamethoxazole]] 10mg (TMP)/kg/day, divided, BID for 5–7 days if susceptible | ||
Revision as of 14:50, 14 September 2019
Background
Clinical Features
Differential Diagnosis
Infection
- Viral
- Rotavirus
- Norovirus, Norwalk virus
- Enterovirus
- Adenovirus
- Bacterial
- Parasitic
Dietary disturbances
- Overfeeding
- Food allergy
- Starvation stools
Anatomic abnormalities
- Intussusception
- Hirschsprung's disease
- Partial SBO
- Appendicitis
- Blind loop syndrome
- Intestinal lymphangiectasia
- Short bowel syndrome
Malabsorption or secretory diseases
- Cystic fibrosis
- Celiac disease
- Disaccharidase deficiency
- Secretory neoplasms
Systemic diseases
- Immunodeficiency
- Endocrinopathy
Miscellaneous
- Inflammatory bowel disease
- Antibiotic-associated diarrhea
- Secondary lactase deficiency
- Irritable colon syndrome
- Neonatal abstinence syndrome
- Toxins
- Hemolytic uremic syndrome
Evaluation
Management
General Treatment
- If bloody diarrhea, use caution with beginning antibiotics in ED before stool culture results
- Some studies demonstrate antibiotic treatment in setting of E.coli O157:H7 leads to increasing risk of hemolytic uremic syndrome (HUS)
Diarrheal Pathogens in Children and Specific Therapy
| AGENT | SPECIFIC THERAPY BEYOND SUPPORTIVE CARE |
|---|---|
| Campylobacter jejuni | Azithromycin 12mg/kg/day PO for 5 days or |
| Erythromycin 30–50mg/kg/day, divided, tid PO for 5–7 days | |
| Clostridium difficile | Metronidazole 30mg/kg/day, divided, QID PO for 7–10 days or |
| Escherichia coli | Azithromycin 12mg/kg/day PO for 5 days or |
| Trimethoprim-sulfamethoxazole 10mg (TMP)/kg/day PO divided BID for 5–7 days | |
| Giardia lamblia | Metronidazole 15mg/kg/day PO, divided, tid for 5 days |
| Salmonella species | In toxic infants <3 mo: Ampicillin 200mg/kg/24 hours q6h for 7–10 days and Gentamicin 5–7.5mg/kg/24 hours q8h IV |
| Shigella species | Azithromycin 12mg/kg/day PO for 5 days or |
| Trimethoprim-sulfamethoxazole 10mg (TMP)/kg/day, divided, BID for 5–7 days if susceptible | |
| Yersinia enterocolitica | If patient is immunosuppressed, treat as for presumed sepsis |
| Vibrio cholera | None; severe diarrhea or cholera may benefit from antibiotics |